Papadaki, M.A.; Sotiriou, A.I.; Vasilopoulou, C.; Filika, M.; Aggouraki, D.; Tsoulfas, P.G.; Apostolopoulou, C.A.; Rounis, K.; Mavroudis, D.; Agelaki, S.
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy. Cancers 2020, 12, 1556.
https://doi.org/10.3390/cancers12061556
AMA Style
Papadaki MA, Sotiriou AI, Vasilopoulou C, Filika M, Aggouraki D, Tsoulfas PG, Apostolopoulou CA, Rounis K, Mavroudis D, Agelaki S.
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy. Cancers. 2020; 12(6):1556.
https://doi.org/10.3390/cancers12061556
Chicago/Turabian Style
Papadaki, Maria A, Afroditi I Sotiriou, Christina Vasilopoulou, Maria Filika, Despoina Aggouraki, Panormitis G Tsoulfas, Christina A Apostolopoulou, Konstantinos Rounis, Dimitrios Mavroudis, and Sofia Agelaki.
2020. "Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy" Cancers 12, no. 6: 1556.
https://doi.org/10.3390/cancers12061556
APA Style
Papadaki, M. A., Sotiriou, A. I., Vasilopoulou, C., Filika, M., Aggouraki, D., Tsoulfas, P. G., Apostolopoulou, C. A., Rounis, K., Mavroudis, D., & Agelaki, S.
(2020). Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy. Cancers, 12(6), 1556.
https://doi.org/10.3390/cancers12061556
